Russo H, Brès J, Duboin MP, Roquefeuil B (1995). "Pharmacokinetics of thiopental after single and multiple intravenous doses in critical care patients". European Journal of Clinical Pharmacology. 49 (1–2): 127–37. doi:10.1007/BF00192371. PMID8751034. S2CID24285007.
Bryson EO (December 2014). "The Abuse of Agents Used to Induce or Maintain General Anesthesia: Intravenous Hypnotics and the Halogenated Hydrocarbons". In Kaye AD, Vadivelu N, Urman RD (eds.). Substance abuse: inpatient and outpatient management for every clinician. New York: Springer. p. 115. doi:10.1007/978-1-4939-1951-2_10. ISBN978-1493919512. OCLC897466425.
World Health Organization (2009). WHO Model List of Essential Medicines 16th list, March 2009. Geneva, Switzerland: World Health Organization. hdl:10665/70642/.
World Health Organization (2012). The selection and use of essential medicines : report of the WHO Expert Committee, March 2011 (including the 17th WHO model list of essential medicines and the 3rd WHO model list of essential medicines for children). Geneva: World Health Organization. hdl:10665/44771. ISBN9789241209656. ISSN0512-3054. WHO technical report series; 965.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
Russo H, Brès J, Duboin MP, Roquefeuil B (1995). "Pharmacokinetics of thiopental after single and multiple intravenous doses in critical care patients". European Journal of Clinical Pharmacology. 49 (1–2): 127–37. doi:10.1007/BF00192371. PMID8751034. S2CID24285007.
Bory C, Chantin C, Boulieu R, Cotte J, Berthier JC, Fraisse D, Bobenrieth MJ (1986). "[Use of thiopental in man. Determination of this drug and its metabolites in plasma and urine by liquid phase chromatography and mass spectrometry]". Comptes Rendus de l'Académie des Sciences, Série III (in French). 303 (1): 7–12. PMID3093002.
"PENTOTHAL". RXList. WebMD. 15 November 2021. Retrieved 18 June 2023.
semanticscholar.org
api.semanticscholar.org
Russo H, Brès J, Duboin MP, Roquefeuil B (1995). "Pharmacokinetics of thiopental after single and multiple intravenous doses in critical care patients". European Journal of Clinical Pharmacology. 49 (1–2): 127–37. doi:10.1007/BF00192371. PMID8751034. S2CID24285007.
Abraham P, Rennert RC, Gabel BC, Sack JA, Karanjia N, Warnke P, Chen CC (December 2017). "ICP management in patients suffering from traumatic brain injury: a systematic review of randomized controlled trials". Acta Neurochirurgica. 159 (12): 2279–2287. doi:10.1007/s00701-017-3363-1. PMID29058090. S2CID3013248.
World Health Organization (2012). The selection and use of essential medicines : report of the WHO Expert Committee, March 2011 (including the 17th WHO model list of essential medicines and the 3rd WHO model list of essential medicines for children). Geneva: World Health Organization. hdl:10665/44771. ISBN9789241209656. ISSN0512-3054. WHO technical report series; 965.
Bryson EO (December 2014). "The Abuse of Agents Used to Induce or Maintain General Anesthesia: Intravenous Hypnotics and the Halogenated Hydrocarbons". In Kaye AD, Vadivelu N, Urman RD (eds.). Substance abuse: inpatient and outpatient management for every clinician. New York: Springer. p. 115. doi:10.1007/978-1-4939-1951-2_10. ISBN978-1493919512. OCLC897466425.